Study of the incidence of invasive pneumococcal disease in neonates and children aged less than 5 years in the Basque country and Navarre (Spain);Estudio de la incidencia de enfermedad neumocócica invasora entre 0-5 años en el País Vasco y Navarra

Anales Espanoles de Pediatria

Volumn 57, Issue 4, 2002, Pages 301-309

  Bernaola Iturbe, E ^a   De Aristegui Fernandez J ^b   Herranz Aguirre, M ^a   Garcia Calvo C ^c   Fernandez Perez C ^d   Pocheville, I ^e   Menendez Bada T ^f   Arranz, L ⁱ   Duran G ⁱ   Perez Diaz L ^g   Bastida, M ^h   Clerigue N ^a   Canduela, C ⁱ  

^a Universidad Pública de Navarra   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c Celltech Pharma España   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g HOSPITAL TXAGORRITXU   (Spain)

^h Hospital Santiago Apóstol   (Brazil)

ⁱ Hospital Virgen del Camino ^*

Author keywords

Bacteremia; Bacteremic pneumonia; Invasive pneumococcal disease; Meningitis

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONFIDENCE INTERVAL; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MEDICAL RECORD; OBSERVATION; PLEURA EFFUSION; PNEUMONIA; POISSON DISTRIBUTION; PRESCHOOL CHILD; PRIVATE HOSPITAL; PUBLIC HOSPITAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEROTYPE; SPAIN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SYMPTOM;

CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; SPAIN;

EID: 0345039871     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sleeman K, Knox K, George R, Miller E, Waight P, Griffiths D, et al. Invasive pneumococcal disease in England and Wales: Vaccination implications. J Infect Dis 2001;183:239-46.
2. Kaltoft MS, Zeuthen N, Konradsen HB. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study. Acta Pediatr 2000;435:3-10.
3. Miller E, Waigt P, Efstratiou A, Brisson M, Johnson A, George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Pediatr 2000;435:11-6.
4. Ziebold C, Von Kries R, Siedler A, Schimitt Hj. Epidemiology of pneumococcal disease in children in Germany. Acta Pediatr 2000;435:17-21.
5. Robinson KA, Baughman W, Rothrocks G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive S. pneumoniae infections in EEUU 1995-1998. JAMA 2001;285:1729-35.
6. Hausdorf WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001;357:950-2.
7. Barraff LJ, Bass JW, Fleisher GR, Klein O, McCracken JR, Powel K, et al. Practice guideline for the management of infants and children 0 to 36 month age with fever without source. Pediatrics 1993;92:1-12.
8. Espin MJ, García J, Ruiz J, Ródenas Jegea A, Navarro JA. Incidencia de enfermedad invasiva por Streptococcus pneumoniae en la región de Murcia. Gaceta Sanitaria de la Sociedad Española de Salud pública y Administración Sanitaria, 2001;15.
9. Dominguez A, Ciruela P, Martinez A, Carmona G, Torner N Cardeñosa N, et al. Epidemiology of invasive pneumococcal disease in infants in catalonia (Spain) Abstrac 127. ESPID, 2001.
10. Pineda V, Domingo M, Larramona H, Pérez A, Segura F, Fontanals D. Incidencia de la infección invasiva por Streptococcus pneumoniae en Sabadell y posible impacto de las nuevas vacunas antineumocócicas conjugadas. Vacunas 2002;01:13-7.
11. Singleton R, Butler J, Waldrep K, Bulkow L, Parcks D, Harker-Jones M, et al. Pneumococcal disease in Alaska children less than 5 years of age 1 year after statewide routine vaccination with 7 valent pneumococcal conjugate vaccine. (Abstract P- 68.) 3rd International Symposium on pneumococci and pneumococcal diseases. ISPPD 2002. Anchorage, Alaska.
12. O'Brien KL, David A, Benson J, Moenne K, Reid R, Moulton L, et al. The effect of conjugate pneumococcal vaccine on pneumonia and otitis media among Navajo and White Mountain Apache children [Abstract p-110]. 3rd International Symposium on pneumococci and pneumococcal diseases. ISSPD 2002; Anchorage, Alaska.
13. Kaplan S, Mason E, Wald ER, Tan T, Schutze G, Bradley J, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 2002;21:141-7.
14. Fenoll A, Jado I, Vicioso D, Berron S, Yuste JE, Casal J. Streptococcuspneumoniae in children in Spain: 1990-1999. Acta Pediatr 2000;435:44-50.
15. Syriopoulou V, Daikos GL, Soulis K, Michos A, Alexandrou H, Pavlopoulou I, et al. Epidemiology of invasive childhood pneumococcal infections in Greece. Acta Pediatr 2000;435:30-4.
16. Casado J, Aristegui J, Rodrigo C, Martinón JM, Fernández C, y Grupo para el Estudio de la Meningitis Neumocócica. Prevalencia de meningitis neumocócica en niños españoles. An Esp Pediatr 2002;56:5-9.
17. Fenoll A, Berrón S, Casado J, Aristegui J, Rodrigo C, Martinón JM, et al Abstract (P-266). Congreso de la Asociación Española de Pediatría Bilbao. An Ped 2002;56(S-5):79.
18. National Committee for Clinical Laboratory Standards (NCCLS). MIC interpretative Standards (μg/ml) for Streptococcus pneumoniae. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. NCCLS document M100-S12, January 2002; Vol 22 N.° 1:110-1.
19. Scheifele D, Halperin S, Pelletier L, Talbot J. Invasive pneumococcal infections in canadian children, 1991-1998: implications for new vaccination strategies. Cin Infect Dis 2000;31:58-64.
20. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen J, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
21. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
22. rd International Symposium on pneumococci and pneumococcal diseases; ISPPD 2002, Anchorage, Alaska.
23. Black SB, Shinefeld H, Hansen J, Elbin L, Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001;20:1105-7.